eosine yellowish-(ys) has been researched along with Cell Transformation, Neoplastic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azueta, A; Espinal, PS; García-Escudero, A; González-Cámpora, R; Pabón-Carrasco, S; Pereira-Gallardo, S; Rodríguez-Zarco, E; Umbría-Jiménez, S; Vallejo-Benítez, A | 1 |
| Conklin, MW; Eliceiri, KW; Keely, PJ; Provenzano, PP; Sullivan, R | 1 |
| Hillery, S; Platell, C; Stewart, CJ | 1 |
| Colaco, AA; De la Cruz P, LF; Lopes, CA; Oliveira, PA; Palmeira, CA | 1 |
| Furuya, K; Mori, H; Williams, GM | 1 |
| Birrer, MJ; Farley, J; Gray, K; Jakowlew, SB; Nycum, L; Prentice, M | 1 |
| Haferlach, T; Hiddemann, W; Lang, NK; Nickenig, C; Schoch, C | 1 |
7 other study(ies) available for eosine yellowish-(ys) and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
Topics: Aged; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cell Transformation, Neoplastic; DNA-Binding Proteins; Eosine Yellowish-(YS); Hematoxylin; Homeodomain Proteins; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Proteins; POU Domain Factors; Prognosis; Prostatic Neoplasms; Staining and Labeling; Synaptophysin; Transcription Factors; Transcription, Genetic | 2017 |
Fluorescence lifetime imaging of endogenous fluorophores in histopathology sections reveals differences between normal and tumor epithelium in carcinoma in situ of the breast.
Topics: Animals; Biomarkers; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Transformation, Neoplastic; Eosine Yellowish-(YS); Epithelial Cells; Epithelium; Flavin-Adenine Dinucleotide; Fluorescence; Hematoxylin; Humans; Mice; Microscopy, Fluorescence, Multiphoton; NAD; Staining and Labeling | 2009 |
Caldesmon is useful in demonstrating extramural venous invasion in colorectal carcinomas showing mucinous differentiation.
Topics: Adenocarcinoma, Mucinous; Adipose Tissue; Biomarkers, Tumor; Calmodulin-Binding Proteins; Cell Transformation, Neoplastic; Colorectal Neoplasms; Elastin; Eosine Yellowish-(YS); Hematoxylin; Humans; Mucins; Neoplasm Invasiveness; Neoplasm Staging; Staining and Labeling; Veins | 2012 |
A phyllodes tumor of the urinary bladder in a rat.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Coloring Agents; DNA, Neoplasm; Eosine Yellowish-(YS); Female; Hematoxylin; Phyllodes Tumor; Rats; Rats, Inbred F344; Rosaniline Dyes; Urinary Bladder Neoplasms | 2007 |
Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats.
Topics: Animals; Carcinogens; Cell Division; Cell Survival; Cell Transformation, Neoplastic; Eosine Yellowish-(YS); Liver; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Transplantation; Phenobarbital; Rats; Rats, Inbred F344; Time Factors | 1983 |
Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Topics: Activin Receptors, Type I; Adenocarcinoma; Carcinoma in Situ; Cell Cycle Proteins; Cell Transformation, Neoplastic; Cervix Uteri; Cyclin-Dependent Kinase Inhibitor p27; Eosine Yellowish-(YS); Female; Genes, Tumor Suppressor; Hematoxylin; Humans; Immunohistochemistry; Ligands; Microtubule-Associated Proteins; Neoplasm Staging; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Staining and Labeling; Transforming Growth Factor beta; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2000 |
New insights into the biology of multiple myeloma using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Topics: Adult; Aged; Antigens, CD34; Bone Marrow Cells; Cell Lineage; Cell Nucleus; Cell Transformation, Neoplastic; Chromosome Aberrations; Coloring Agents; Eosine Yellowish-(YS); Female; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Male; Methylene Blue; Middle Aged; Multiple Myeloma; Plasma Cells; Staining and Labeling; Trisomy | 2001 |